This announcement is a separate document:
派林生物:2023年度就补偿期限届满对购买资产减值测试的专项审核意见
Pacific Shuanglin Bio-pharmacy: 2023 Special Audit Opinions on Impairment Tests for Purchased Assets on the Expiration of the Compensation Period
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.